BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 19644423)

  • 1. Expression of the human Bcl-2 increases resistance of Ewing's sarcoma cells to apoptosis and inhibits poly(ADP-ribose) polymerase cleavage induced by radiation.
    Soldatenkov V; Notario V; Dritschilo A
    Int J Oncol; 1996 Sep; 9(3):547-51. PubMed ID: 21541549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial marker expression does not rule out a diagnosis of Ewing's sarcoma family of tumours.
    Machado I; Navarro S; López-Guerrero JA; Alberghini M; Picci P; Llombart-Bosch A
    Virchows Arch; 2011 Oct; 459(4):409-14. PubMed ID: 21887539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of neuron-specific enolase and Leu 7 in Ewing's sarcoma of bone.
    Pinto A; Grant LH; Hayes FA; Schell MJ; Parham DM
    Cancer; 1989 Sep; 64(6):1266-73. PubMed ID: 2670185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary intradural extramedullary extraosseous Ewing's sarcoma/peripheral primitive neuroectodermal tumor (PIEES/PNET) of the thoracolumbar spine: A case report and literature review.
    Pu F; Liu J; Zhang Z; Guo T; Shao Z
    Open Med (Wars); 2021; 16(1):1591-1596. PubMed ID: 34722894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia.
    Vaikari VP; Park M; Keossayan L; MacKay JA; Alachkar H
    Nanomedicine; 2020 Oct; 29():102236. PubMed ID: 32535112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.
    Vaikari VP; Du Y; Wu S; Zhang T; Metzeler K; Batcha AMN; Herold T; Hiddemann W; Akhtari M; Alachkar H
    Haematologica; 2020 Apr; 105(4):999-1012. PubMed ID: 31371417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.
    Martinelli M; Parra A; Scapoli L; De Sanctis P; Chiadini V; Hattinger C; Picci P; Zucchini C; Scotlandi K
    Oncotarget; 2016 Nov; 7(47):77958-77967. PubMed ID: 27792997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance?
    Machado I; López-Guerrero JA; Navarro S; Alberghini M; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2012 Sep; 461(3):333-7. PubMed ID: 22898789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience.
    Weiss KR; Biau DJ; Bhumbra R; Griffin AM; Blackstein ME; Chung P; Catton C; O'Sullivan B; Ferguson PC; Wunder JS
    Sarcoma; 2011; 2011():395180. PubMed ID: 22190863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.
    Dai X; Ma W; He X; Jha RK
    Med Sci Monit; 2011 Aug; 17(8):RA177-190. PubMed ID: 21804475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis.
    Kowalewski AA; Randall RL; Lessnick SL
    Sarcoma; 2011; 2011():598704. PubMed ID: 21052502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological study of Ewing's sarcoma/primitive neuroectodermal tumor in oral and maxillofacial region].
    He HW; Liu LK; Li YN; Wang D; He ZX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Sep; 40(5):379-82. PubMed ID: 16255919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study.
    Ilić I; Manojlović S; Cepulić M; Orlić D; Seiwerth S
    Croat Med J; 2004 Dec; 45(6):740-5. PubMed ID: 15578809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship.
    Lahl M; Fisher VL; Laschinger K
    Clin J Oncol Nurs; 2008 Feb; 12(1):89-97. PubMed ID: 18258578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to treat the Ewing's family of sarcomas in adult patients.
    Scurr M; Judson I
    Oncologist; 2006 Jan; 11(1):65-72. PubMed ID: 16401715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunohistochemistry in the Ewing's sarcoma family of tumors.
    Kavalar R; Pohar Marinsek Z; Jereb B; Cagran B; Golouh R
    Med Sci Monit; 2009 Aug; 15(8):CR442-52. PubMed ID: 19644423
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.